Skip to content
FREE SHIPPING ON ORDERS OVER $500
0
New Tool Protocol Builder
Master Guides

MK-677 (Ibutamoren) in Canada: What It Does and What It Is Not

GH GHCanada Team 6 min read
MK-677 (Ibutamoren) in Canada: What It Does and What It Is Not

MK-677 sits on the SARM shelf at nearly every supplier in the country, and it is not a SARM. It does not touch the androgen receptor, it does not shut down your natural testosterone, and nothing about how it works resembles Ostarine or RAD-140. It is an oral growth hormone secretagogue. That is a d…

In this article
  1. What it actually is
  2. What the research found
  3. The appetite is not a side effect, it is the mechanism
  4. What else shows up
  5. Dosing in the literature
  6. MK-677 against injectable HGH
  7. Things worth knowing before you order
  8. Where it fits

MK-677 sits on the SARM shelf at nearly every supplier in the country, and it is not a SARM. It does not touch the androgen receptor, it does not shut down your natural testosterone, and nothing about how it works resembles Ostarine or RAD-140.

It is an oral growth hormone secretagogue. That is a different category entirely, and the difference matters for what it does, what it costs you, and what happens when you stop.

What it actually is

Ibutamoren, compound code MK-677, is a non-peptide molecule Merck developed in the 1990s. It mimics ghrelin, the hormone your stomach releases when it is empty, by binding the growth hormone secretagogue receptor in the pituitary and hypothalamus.

Your pituitary responds the way it would to a natural ghrelin pulse: it releases growth hormone. Downstream, the liver converts that signal into IGF-1.

The practical difference from injectable HGH is that you are telling your own pituitary to fire rather than putting hormone into your body from outside. The pulses stay roughly where your body normally puts them, and there is no needle involved.

The practical difference from a SARM is that there is no hormonal axis being suppressed, because you never introduced an androgen.

What the research found

The study people cite is Nass and colleagues, published in Annals of Internal Medicine in 2008. Sixty-five healthy adults in their sixties and seventies took 25 mg daily for two years.

Growth hormone and IGF-1 came back up to the levels of healthy young adults. Lean mass rose by roughly 1.1 kg against placebo.

The part that gets left out of the sales copy: strength and function did not improve. Participants gained lean tissue without gaining measurable performance. Fasting blood glucose went up and insulin sensitivity went down.

Merck took the compound through trials for hip fracture recovery and for frailty and never brought it to market. It is not approved anywhere, for anything.

The appetite is not a side effect, it is the mechanism

This is the single most reported thing about MK-677 and it surprises people who were not expecting it.

Ghrelin is the hunger hormone. A ghrelin mimetic makes you hungry. Not mildly interested in food, properly hungry, often within the first few days and often at times you would not normally eat.

For someone trying to add size on a surplus, that is the whole point and it is doing its job. For someone running a cut, it is close to unusable. People go in expecting a mild recomposition aid and discover they are fighting their own appetite at eleven at night.

Decide which of those two situations you are in before you start, because the compound does not care about your intentions.

What else shows up

Water retention. Common and often noticeable in the first fortnight. Puffiness in the face and hands, a few pounds on the scale that are not tissue.

Numbness and tingling in the hands. Reported frequently enough to be worth naming. It is the same carpal-tunnel-type pressure that shows up with growth hormone itself, and it tracks with the fluid retention.

Blood glucose. This is the one that deserves attention rather than a shrug. Growth hormone opposes insulin. Raising GH chronically raises fasting glucose and reduces insulin sensitivity, and the two-year data showed exactly that. If diabetes runs in your family, or your fasting glucose is already at the upper end, this is a real consideration and not a theoretical one.

Lethargy. Some people report heavy, sluggish mornings. Others report the opposite and sleep better than they have in years. It splits.

What does not show up is testosterone suppression. There is no androgen involved, so there is no axis to recover. People who come off MK-677 and run a post cycle therapy protocol are treating it like something it is not.

Dosing in the literature

We are not writing you a protocol. What we can tell you is what the trials used, because that is published and checkable.

Clinical work has run at 25 mg daily. Chapman and colleagues used 25 mg in their 1996 work on IGF-1 response. Nass used 25 mg for two years. Earlier dose-finding work went both above and below that.

The half-life is in the region of 24 hours, which is why it is taken once a day rather than split. Timing is argued about endlessly and the evidence that it matters is thin. People who find it sedating take it at night. People who find it sedating in the morning take it at night too.

If you want the fuller picture on how growth hormone signalling works before deciding anything, our guide on dosing HGH properly covers the same axis from the other direction.

MK-677 against injectable HGH

The honest comparison, since this is the decision most people are actually making.

MK-677 Injectable HGH
Route Oral, once daily Subcutaneous injection
Mechanism Signals your pituitary Supplies hormone directly
Release pattern Follows your own pulses Whatever you inject, when you inject it
Appetite Strongly increased Not a primary effect
Cost per month Low Considerably higher
Testosterone suppression None None
Effect on insulin sensitivity Reduces it Reduces it

Both end up raising IGF-1. The route, the cost and the hunger are what separate them. If price is the deciding factor, our breakdown of the cheapest HGH in Canada is worth reading alongside this.

Things worth knowing before you order

MK-677 is not approved by Health Canada for any use. It is sold here for research purposes and nothing on this page is medical advice.

If you are going to run it, get bloodwork first and get it again at eight to twelve weeks. Fasting glucose, HbA1c and IGF-1 are the three that tell you whether it is doing what you think it is doing and whether it is costing you something on the metabolic side. Running it blind means you find out about the glucose problem later and from a worse direction.

It stacks logically with nothing in particular. It is not an anabolic and pairing it with one does not change how either behaves.

Where it fits

MK-677 is a reasonable choice for someone in a surplus who wants help eating, better sleep, and a slow improvement in recovery and tissue quality over months rather than weeks. Two years of data produced about a kilogram of lean mass. It is not fast and it was never going to be.

It is a poor choice for someone cutting, someone with blood sugar they are already watching, or someone expecting the strength curve of an actual anabolic.

We stock Ibutamoren MK-677 at $80. If you are weighing it against the injectable route instead, start with the HGH myths piece and come back to this one.

Sold for research purposes only. Not approved by Health Canada and not intended to diagnose, treat, cure or prevent any disease. Nothing here is medical advice. Speak to a physician before using any compound discussed on this page, particularly if you have impaired glucose tolerance, diabetes, or a family history of either.

This article is for educational and research purposes only and is not medical advice. Speak to a qualified professional and get bloodwork before using any compound.

Keep reading